Vertex Pharmaceuticals Incorporated shares owned by Pictet Asset Management
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Pictet Asset Management
from 13F filings
Historical chart of Pictet Asset Management investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Pictet Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Pictet Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2021-06-30 | $261M | 1.3M | 201.63 |
| 2021-03-31 | $267M | 1.2M | 214.89 |
| 2020-12-31 | $323M | 1.4M | 236.34 |
| 2020-09-30 | $267M | 981k | 272.12 |
| 2020-06-30 | $329M | 1.1M | 290.31 |
| 2020-03-31 | $220M | 926k | 237.95 |
| 2019-12-31 | $224M | 1.0M | 218.95 |
| 2019-09-30 | $198M | 1.2M | 169.42 |
| 2019-06-30 | $208M | 1.1M | 183.38 |
| 2019-03-31 | $194M | 1.1M | 183.95 |
| 2018-12-31 | $165M | 996k | 165.71 |
| 2018-09-30 | $211M | 1.1M | 192.74 |
| 2018-06-30 | $206M | 1.2M | 169.96 |
| 2018-03-31 | $196M | 1.2M | 162.98 |
| 2017-12-31 | $179M | 1.2M | 149.86 |
| 2017-09-30 | $156M | 1.0M | 152.04 |
| 2017-06-30 | $148M | 1.2M | 123.60 |
| 2017-03-31 | $140M | 1.3M | 109.35 |
| 2016-12-31 | $83M | 1.1M | 73.67 |
| 2016-09-30 | $84M | 965k | 87.21 |
| 2016-06-30 | $76M | 815k | 93.15 |
| 2016-03-31 | $25M | 289k | 85.49 |
| 2015-12-31 | $44M | 349k | 125.83 |
| 2015-09-30 | $35M | 337k | 104.14 |
| 2015-06-30 | $54M | 397k | 135.00 |
| 2015-03-31 | $31M | 247k | 123.28 |
| 2014-12-31 | $27M | 227k | 118.80 |
| 2014-09-30 | $17M | 152k | 112.31 |
| 2014-06-30 | $26M | 279k | 94.68 |
| 2014-03-31 | $18M | 248k | 70.72 |
| 2013-12-31 | $18M | 241k | 74.30 |
| 2013-09-30 | $19M | 244k | 75.82 |
| 2013-06-30 | $18M | 230k | 79.87 |
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated